alexa Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments.
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmaceutica Analytica Acta

Author(s): Pratt N, Roughead EE, Ryan P, Salter A

Abstract Share this page

Abstract PURPOSE: Observational studies have investigated the comparative safety of antipsychotics with varying results. Instrumental variable analysis has been suggested as a possible alternative to conventional analyses when there is concern about the effect of unmeasured confounding in observational studies. Using the example of the risk of death with typical compared to atypical antipsychotics, we aimed to explore the performance of two different instruments. We used the doctor prescribing preference instrument, which has been used in previous studies, to investigate further the assumptions of this instrument in the Australian population. We also propose an alternative instrument, nursing home facility preference. METHODS: With the Australian Department of Veterans' Affairs administrative claims database, we used an instrumental variable analysis to compare the risk of death after 12 months between the two antipsychotic classes. RESULTS: Using the doctor prescribing preference instrument we estimated that typical antipsychotics were associated with an extra 24 (95\% Confidence Interval (CI) 18-30) deaths per 100 patients per year compared to atypical antipsychotics, and an extra 10 (95\% CI 7-14) deaths per 100 patients per year among nursing home residents. Facility prescribing preference was a stronger instrument (OR=19.2 95\% CI 17.1-21.6) and provided a better balance of covariates than doctor prescribing preference. CONCLUSIONS: Our study has shown that valid instruments in one population may not be directly applicable to other health care settings and testing of assumptions is crucial when performing IV analyses. Facility prescribing preference appears to be a potentially valid instrument for further work in this area. (c) 2010 John Wiley & Sons, Ltd. This article was published in Pharmacoepidemiol Drug Saf and referenced in Pharmaceutica Analytica Acta

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords